Cargando…

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease

ABSTRACT: Radiotherapy is frequently used in the therapy of lymphoma. Since lymphoma, for example Hodgkin’s disease, frequently affect rather young patients, the induction of secondary cancer or other long-term adverse effects after irradiation are important issues to deal with. Especially for media...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lautenschlaeger, S., Iancu, G., Flatten, V., Baumann, K., Thiemer, M., Dumke, C., Zink, K., Hauswald, H., Vordermark, D., Mauz-Körholz, C., Engenhart-Cabillic, R., Eberle, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721251/ https://www.ncbi.nlm.nih.gov/pubmed/31477141 http://dx.doi.org/10.1186/s13014-019-1360-7

Ejemplares similares

Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
por: Baumann, Kilian-Simon, et al.
Publicado: (2019)

Correction to: Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
por: Baumann, Kilian-Simon, et al.
Publicado: (2020)

Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
por: Lautenschlaeger, F. S., et al.
Publicado: (2021)

A phantom based evaluation of the dose prediction and effects in treatment plans, when calculating on a direct density CT reconstruction
por: Flatten, Veronika, et al.
Publicado: (2020)

Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy
por: Dumke, R., et al.
Publicado: (2022)

Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy
por: Eberle, Fabian, et al.
Publicado: (2022)

Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic: Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance
por: Oertel, M., et al.
Publicado: (2020)

The fast calibration model for dosimetry with an electronic portal imaging device
por: Schade, Stephanie, et al.
Publicado: (2022)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
por: Eberle, Fabian, et al.
Publicado: (2020)

Long-term results of radiotherapy in anaplastic thyroid cancer
por: Dumke, Anne-Katrin, et al.
Publicado: (2014)

Making the right software choice for clinically used equipment in radiation oncology
por: Vorwerk, Hilke, et al.
Publicado: (2014)

Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors
por: Ammazzalorso, Filippo, et al.
Publicado: (2014)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
por: Daw, Stephen, et al.
Publicado: (2020)

Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
por: Oertel, Michael, et al.
Publicado: (2022)

Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial
por: Oertel, Michael, et al.
Publicado: (2023)

Dosimetric impact of reduced nozzle-to-isocenter distance in intensity-modulated proton therapy of intracranial tumors in combined proton-carbon fixed-nozzle treatment facilities
por: Jelen, Urszula, et al.
Publicado: (2013)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
por: Oertel, Michael, et al.
Publicado: (2022)

Students’ learning behavior in digital education for radiation oncology
por: Vorwerk, Hilke, et al.
Publicado: (2021)

P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
por: Oertel, Michael, et al.
Publicado: (2022)

Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
por: Wächter, Sabine, et al.
Publicado: (2023)

P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group
por: Oertel, Michael, et al.
Publicado: (2022)

Expression of Dual-Specificity Phosphatase 5 Pseudogene 1 (DUSP5P1) in Tumor Cells
por: Staege, Martin S., et al.
Publicado: (2014)

The results of radiotherapy for Hodgkins' disease.
por: Peckham, M. J., et al.
Publicado: (1975)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
por: Kluge, Regine, et al.
Publicado: (2016)

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
por: Mauz-Körholz, Christine, et al.
Publicado: (2022)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

The Majority of United States Citizens With Cancer do not Have Access to Carbon Ion Radiotherapy
por: Foote, Robert L., et al.
Publicado: (2022)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
por: Georgi, Thomas W, et al.
Publicado: (2022)

In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed
por: Eberle, Fabian, et al.
Publicado: (2017)

Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines
por: Subtil, Florentine S. B., et al.
Publicado: (2022)

Siah1 proteins enhance radiosensitivity of human breast cancer cells
por: He, Hai-Tao, et al.
Publicado: (2010)

Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
por: Santiago, Alina, et al.
Publicado: (2016)

Changes of lung parenchyma density following high dose radiation therapy for thoracic carcinomas – an automated analysis of follow up CT scans
por: Schröder, Christina, et al.
Publicado: (2019)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

Proton Radiotherapy for Pediatric Sarcoma
por: Ladra, Matthew M., et al.
Publicado: (2014)

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
por: Harker-Murray, Paul, et al.
Publicado: (2023)

Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial
por: Teymoortash, Afshin, et al.
Publicado: (2016)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Advantages of mini-multileaf in stereotactic radiotherapy
por: Kurup, P. G. G., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jcmpbo3hjobi92bkr157jivema